Ohio Public Employees Retirement System (OPERS)
URGN icon

Ohio Public Employees Retirement System (OPERS)’s UroGen Pharma URGN Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,200
Closed -$54K – 2039
2022
Q1 		$54K Hold
6,200
– – ﹤0.01% 1865
2021
Q4 		$59K Hold
6,200
– – ﹤0.01% 1865
2021
Q3 		$104K Hold
6,200
– – ﹤0.01% 1703
2021
Q2 		$95K Sell
6,200
-700
-10% -$12.7K ﹤0.01% 1723
2021
Q1 		$134K Buy
6,900
+1,200
+21% +$25.5K ﹤0.01% 1589
2020
Q4 		$103K Buy
+5,700
New +$119K ﹤0.01% 1596

Other funds holding URGN

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s URGN Position: Q2 2022 in Review

Ohio Public Employees Retirement System (OPERS) sold out of UroGen Pharma (URGN) in Q2 2022, closing a stake of 6,200 shares — an estimated $54K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in URGN in Q4 2020 and held it in 6 quarters. The position peaked at $134K in Q1 2021. 65 funds tracked by Wall St. Rank hold URGN as of Q2 2022.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining UroGen Pharma position as of Q2 2022 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 6,200 UroGen Pharma shares in Q2 2022, an estimated $54K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in UroGen Pharma in Q4 2020 and held it in 6 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s UroGen Pharma position peaked at $134K in Q1 2021.
  • 65 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2022.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2022, filed 15 Aug 2022.